PVI
TNDM icon

Pura Vida Investments’s Tandem Diabetes Care TNDM Stock Holding History

Pura Vida Investments’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,000
Closed -$1.27M – 43
2024
Q3 		$1.27M Buy
+30,000
New +$1.27M 0.83% 31
2024
Q1 		– Sell
-75,000
Closed -$2.22M – 71
2023
Q4 		$2.22M Buy
+75,000
New +$1.56M 0.34% 34
2022
Q4 		– Sell
-100,000
Closed -$4.79M – 246
2022
Q3 		$4.79M Buy
+100,000
New +$5.48M 0.28% 87

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pura Vida Investments's TNDM Position: Q3 2024 in Review

Pura Vida Investments sold out of Tandem Diabetes Care (TNDM) in Q3 2024, closing a stake of 40,500 shares — an estimated $1.72M sold.

Pura Vida Investments first reported a position in TNDM in Q1 2015 and held it in 10 quarters. The position peaked at $3.68M in Q4 2018. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

  • Pura Vida Investments reported no remaining Tandem Diabetes Care position as of Q3 2024 after selling out during the quarter.
  • Pura Vida Investments sold 40,500 Tandem Diabetes Care shares in Q3 2024, an estimated $1.72M.
  • Pura Vida Investments first reported a position in Tandem Diabetes Care in Q1 2015 and held it in 10 quarters.
  • Pura Vida Investments's Tandem Diabetes Care position peaked at $3.68M in Q4 2018.
  • 332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on Pura Vida Investments's 13F filing for Q3 2024, filed 14 Nov 2024.